[Efficacy and safety of domestic and brand name bortezomib in the treatment of newly diagnosed multiple myeloma]

Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 14;41(3):261-263. doi: 10.3760/cma.j.issn.0253-2727.2020.03.015.
[Article in Chinese]
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Bortezomib / therapeutic use*
  • Dexamethasone
  • Humans
  • Multiple Myeloma* / drug therapy
  • Treatment Outcome

Substances

  • Bortezomib
  • Dexamethasone

Grants and funding

基金项目:国家自然科学基金青年项目(81700138)